Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Sort descending Journal Bone Marrow Disease
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Aplastic Anemia
Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents Leukemia Research Myelodysplastic Syndromes (MDS)
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading? Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS)
Parsing the Paradox of Myelodysplastic Syndromes Journal of clinical oncology: official journal of the American Society Clinical Oncologysd Myelodysplastic Syndromes (MDS)
Outpatient transfusions for myelodysplastic syndromes Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Therapy for lower-risk MDS Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Existing agents, novel agents, or transplantation for high-risk MDS Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes Hematology/oncology and stem cell therapy Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria Blood, cells, molecules & diseases Paroxysmal Nocturnal Hemoglobinuria (PNH)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.